Área salud
Management of Cutaneous Squamous Cell Carcinoma: Review Based on Guidelines. Part 2: Treatment and Follow-up
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Although most cases follow an indolent course, a subset of patients may develop locally advanced or metastatic disease. This review provides a comparative […]
Área salud
Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience From 2 Tertiary Referral Centers
Introduction Clinical trials have validated the use of nivolumab and pembrolizumab as adjuvant therapies regarding relapse-free survival in patients with resected stage III and IV melanoma. Evidence in real-world patients is currently limited. Material and […]
Área salud
[Translated article] Sarcoid-like Reactions to Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICIs) can cause immune-mediated cutaneous adverse events, including sarcoid-like reactions. The aim of this study was to retrospectively analyze clinical and histologic data from patients who developed cutaneous sarcoid-like reactions between 2019 […]